dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fernández-Rozadilla, Ceres |
dc.contributor.author | Simões, Ana Rita |
dc.contributor.author | Carnero, Amancio |
dc.contributor.author | Carracedo, Ángel |
dc.contributor.author | Lleonart Pajarin, Matilde |
dc.date.accessioned | 2022-06-08T09:45:36Z |
dc.date.available | 2022-06-08T09:45:36Z |
dc.date.issued | 2021-01 |
dc.identifier.citation | Fernandez-Rozadilla C, Simões AR, Lleonart ME, Carnero A, Carracedo Á. Tumor Profiling at the Service of Cancer Therapy. Front Oncol. 2021 Jan;10:3038. |
dc.identifier.issn | 2234-943X |
dc.identifier.uri | https://hdl.handle.net/11351/7641 |
dc.description | Cancer treatment; Personalized medicine; Precision oncology |
dc.description.abstract | Cancer treatment options have evolved significantly in the past few years. From the initial surgical procedures, to the latest next-generation technologies, we are now in the position to analyze and understand tumors in a one-by-one basis and use that to our advantage to provide with individualized treatment options that may increase patient survival. In this review, we will focus on how tumor profiling has evolved over the past decades to deliver more efficient and personalized treatment options, and how novel technologies can help us envisage the future of precision oncology toward a better management and, ultimately, increased survival. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Oncology;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Medicina personalitzada |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /therapy |
dc.subject.mesh | Precision Medicine |
dc.title | Tumor Profiling at the Service of Cancer Therapy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fonc.2020.595613 |
dc.subject.decs | neoplasias |
dc.subject.decs | /terapia |
dc.subject.decs | medicina de precisión |
dc.relation.publishversion | https://doi.org/10.3389/fonc.2020.595613 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fernandez-Rozadilla C, Simões AR] Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. [Lleonart ME] Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d´Hebron Institut de Recerca (VHIR), Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain. [Carnero A] Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain. Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Seville, Spain. [Carracedo Á] Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain |
dc.identifier.pmid | 33505911 |
dc.identifier.wos | 000611285600001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |